Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
9.29
+0.43 (4.85%)
At close: Jun 26, 2026, 4:00 PM EDT
9.10
-0.19 (-2.05%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Solid Biosciences Market Cap
Solid Biosciences has a market cap or net worth of $914.6 million as of June 26, 2026. Its market cap has increased by 155.97% in one year.
Market Cap
914.60M
Enterprise Value
554.58M
1-Year Change
155.97%
Ranking
Category
Stock Price
$9.29
Market Cap Chart
Since January 26, 2018, Solid Biosciences's market cap has increased from $754.10M to $914.60M, an increase of 21.28%. That is a compound annual growth rate of 2.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 914.60M | 108.15% |
| Dec 31, 2025 | 439.40M | 174.97% |
| Dec 31, 2024 | 159.80M | 28.97% |
| Dec 29, 2023 | 123.90M | 205.93% |
| Dec 30, 2022 | 40.50M | -79.02% |
| Dec 31, 2021 | 193.00M | -57.88% |
| Dec 31, 2020 | 458.20M | 123.95% |
| Dec 31, 2019 | 204.60M | -78.45% |
| Dec 31, 2018 | 949.60M | 25.92% |
| Jan 26, 2018 | 754.10M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Replimune Group | 960.32M |
| Avalo Therapeutics | 956.69M |
| Alto Neuroscience | 948.94M |
| Pharming Group | 939.20M |
| LB Pharmaceuticals | 915.36M |
| Janux Therapeutics | 911.11M |
| Theravance Biopharma | 908.88M |
| Evommune | 906.94M |